Capital Bancorp Inc
For the period ended Mar 31, 2026. Filed May 8, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 8, 2026
CBNK$42.39-0.5%Stored close · as of Nov 6, 2026
Contents
Item 1. Consolidated Balance Sheets
| Capital Bancorp, Inc. and SubsidiariesConsolidated Balance Sheets (unaudited) | ||
|---|---|---|
| (in thousands, except share data) | March 31, 2026 | December 31, 2025 |
| Assets | ||
| Cash and due from banks | $20,182 | $30,894 |
| Interest-bearing deposits at other financial institutions | 379,069 | 224,611 |
| Federal funds sold | 60 | 60 |
| Total cash and cash equivalents | 399,311 | 255,565 |
| Investment securities available-for-sale | 230,525 | 230,083 |
| Restricted investments | 8,691 | 8,397 |
| Loans held for sale | 13,739 | 25,828 |
| Portfolio loans receivable, net of deferred fees and costs | 3,026,431 | 2,959,457 |
| Less allowance for credit losses | (54,680) | (54,660) |
| Total portfolio loans held for investment, net | 2,971,751 | 2,904,797 |
| Premises and equipment, net | 17,732 | 15,072 |
| Accrued interest receivable | 16,795 | 16,695 |
| Goodwill | 25,969 | 25,969 |
| Intangible assets | 14,511 | 14,771 |
| Loan servicing assets | 1,957 | 1,816 |
| Deferred tax asset | 15,187 | 14,992 |
| Bank owned life insurance | 45,871 | 45,488 |
| Other assets | 46,428 | 46,734 |
| Total assets | $3,808,467 | $3,606,207 |
| Liabilities | ||
| Deposits | ||
| Noninterest-bearing | $871,677 | $852,741 |
| Interest-bearing | 2,420,370 | 2,240,459 |
| Total deposits | 3,292,047 | 3,093,200 |
| Federal Home Loan Bank advances | 50,000 | 50,000 |
| Other borrowed funds | 2,062 | 2,062 |
| Accrued interest payable | 8,944 | 8,745 |
| Other liabilities | 46,555 | 50,443 |
| Total liabilities | 3,399,608 | 3,204,450 |
| Stockholders' equity | ||
| Common stock, $0.01 par value; 49,000,000 shares authorized; 16,286,480 issued and outstanding at March 31, 2026;16,373,288 issued and outstanding at December 31, 2025 | 163 | 164 |
| Additional paid-in capital | 112,268 | 114,604 |
| Retained earnings | 302,808 | 292,749 |
| Accumulated other comprehensive loss | (6,380) | (5,760) |
| Total stockholders' equity | 408,859 | 401,757 |
| Total liabilities and stockholders' equity | $3,808,467 | $3,606,207 |
See accompanying Notes to Unaudited Consolidated Financial Statements
2
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.